ZMPSTE24 and progeroid syndrome: The treatment with farnesyltransferase inhibitors of two progeria mouse models, ZMPSTE24-deficient mice and LMNAHG/+ knock in mice, ameliorates the disease phenotype but not completely, and all treated mice eventually develop severe phenotypes and prematurely die [37–39].